Use of HDAC and/or DNMT inhibitors for treatment of ischemic injury
US8889742B2 · kind B2 · utility
4Cited by
1References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 30, 2005 |
| Grant date | Nov 18, 2014 |
| Priority date | — |
| Expiry date | May 23, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods of ameliorating or reducing the extent of ischemic injury, reperfusion injury, and myocardial infarction, by administering an inhibitor of histone deacetylase enzyme (HDAC) or an inhibitor of DNA methyltransferase enzyme (DNMT).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.